|  | 
| Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, Yun Hong Cheon, Sang-Il Lee, Sang-Hyon Kim, Jae Hyun Jung, Geun-Tae Kim, Jin-Wuk Hur, Myeung-Su Lee, Yun Sung Kim, Seung-Jae Hong, Suyeon Park, Hyun-Sook Kim 
		Korean J Intern Med. 2024;39(5):855-864.   Published online 2024 Aug 30		    DOI: https://doi.org/10.3904/kjim.2023.207
			 | 
| Citations to this article as recorded by  Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, Yun Hong Cheon, Sang-Hyon Kim, Jae Hyun Jung, Geun-Tae Kim, Jin-Wuk Hur, Myeung-Su Lee, Chong Hyuk Chung, Yun Sung Kim, Seung-Jae Hong, Hae-Rim Kim, Hong Ki Min, Se Hee Kim, Su-Jin Moon, Sung Hae Chang, Soojin Im Diagnostics.2025; 15(7): 800.     CrossRef Folate receptor-mediated targeting strategies for potential management & treatment of rheumatoid arthritis Afifa Shafiq, Hassan Shah, Aslam Khan, Safiullah Khan, Faizan Akram, Mamuna Shafique, Faisal Sattar, Muhammad Farhan Hanif, Muhammad Saad Hashmat, Asadullah Madni Journal of Drug Delivery Science and Technology.2025; 108: 106916.     CrossRef Updated systematic literature review and meta-analysis to inform the Italian Society of Rheumatology Recommendations on the treatment of rheumatoid arthritis-associated interstitial lung disease A. Fassio, M. Sebastiani, F. Pollastri, F. Cozzini, C. Crotti, N. Ughi, E. De Lorenzis, S. Mancuso, M. Radin, G. Carrara, G. Landolfi, D. Rozza, A. Manfredi Autoimmunity Reviews.2025; 24(12): 103922.     CrossRef Hydroxychloroquine/Methotrexate/Sulfasalazine Reactions Weekly.2024; 2030(1): 221.     CrossRef |